Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Remdesivir for the Treatment of Covid-19 — Preliminary Report
James McMahon, Andrew Udy, Anton Y. Peleg
New England Journal of Medicine (2020) Vol. 383, Iss. 10, pp. 992-994
Open Access | Times Cited: 1430

Showing 1-25 of 1430 citing articles:

Dexamethasone in Hospitalized Patients with Covid-19
Peter Horby, Wei Shen Lim, Jonathan Emberson, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 8, pp. 693-704
Open Access | Times Cited: 7610
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu, Hua Guo, Peng Zhou, et al.
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 141-154
Open Access | Times Cited: 4749
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman, David Chien Lye, David S.C. Hui, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 19, pp. 1827-1837
Open Access | Times Cited: 1381
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen, Ajay Nirula, Barry N. Heller, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 3, pp. 229-237
Open Access | Times Cited: 1347
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone, Matthew J. Frigault, Naomi Serling‐Boyd, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 24, pp. 2333-2344
Open Access | Times Cited: 1311
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga, Dao Wen Wang, Yaling Han, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 543-558
Open Access | Times Cited: 1303
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner, et al.
JAMA (2020) Vol. 324, Iss. 11, pp. 1048-1048
Open Access | Times Cited: 1177
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Alexandre Biasi Cavalcanti, Fernando G Zampieri, Régis Goulart Rosa, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 21, pp. 2041-2052
Open Access | Times Cited: 1072
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen, Daniel R. Sandoval, Charlotte B. Spliid, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1043-1057.e15
Open Access | Times Cited: 1047
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Iván O. Rosas, Norbert Bräu, Michael R. Waters, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 16, pp. 1503-1516
Open Access | Times Cited: 953
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim, Jae Hyun Bae, Hyuk‐Sang Kwon, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 1, pp. 11-30
Open Access | Times Cited: 925
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Ventura Simonovich, Leandro Daniel Burgos Pratx, Paula Scibona, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 7, pp. 619-629
Open Access | Times Cited: 908
SARS-CoV-2 viral load is associated with increased disease severity and mortality
Jesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 848
COVID-19 and multisystem inflammatory syndrome in children and adolescents
Li Jiang, Kun Tang, Michael Levin, et al.
The Lancet Infectious Diseases (2020) Vol. 20, Iss. 11, pp. e276-e288
Open Access | Times Cited: 792
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
Derek C. Angus, Lennie Derde, Farah Al-Beidh, et al.
JAMA (2020) Vol. 324, Iss. 13, pp. 1317-1317
Open Access | Times Cited: 761
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux, et al.
JAMA Internal Medicine (2020) Vol. 181, Iss. 1, pp. 32-32
Open Access | Times Cited: 722
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo, et al.
Cell (2020) Vol. 184, Iss. 2, pp. 476-488.e11
Open Access | Times Cited: 714
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
Anant Parasher
Postgraduate Medical Journal (2020) Vol. 97, Iss. 1147, pp. 312-320
Open Access | Times Cited: 705
Acute respiratory distress syndrome
Nuala J. Meyer, Luciano Gattinoni, Carolyn S. Calfee
The Lancet (2021) Vol. 398, Iss. 10300, pp. 622-637
Open Access | Times Cited: 701
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Mitra K. Nadim, Lui G. Forni, Ravindra L. Mehta, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 12, pp. 747-764
Open Access | Times Cited: 612
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Florian Kabinger, Carina Stiller, Jana Schmitzová, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 9, pp. 740-746
Open Access | Times Cited: 597
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Jatin Machhi, Jonathan Herskovitz, Ahmed M. Senan, et al.
Journal of Neuroimmune Pharmacology (2020) Vol. 15, Iss. 3, pp. 359-386
Open Access | Times Cited: 587
Artificial intelligence in COVID-19 drug repurposing
Yadi Zhou, Fei Wang, Jian Tang, et al.
The Lancet Digital Health (2020) Vol. 2, Iss. 12, pp. e667-e676
Open Access | Times Cited: 535
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Caleb P Skipper, Katelyn A Pastick, Nicole Engen, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 8, pp. 623-631
Open Access | Times Cited: 533
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Goran Kokić, Hauke S. Hillen, Dimitry Tegunov, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 533
Page 1 - Next Page

Scroll to top